|
LARP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.363700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.202860E-03 |
| Normal-vs-Stage2 |
7.703000E-01 |
| Normal-vs-Stage3 |
7.95920000000727E-05 |
| Normal-vs-Stage4 |
1.041430E-03 |
| Stage1-vs-Stage2 |
9.200000E-03 |
| Stage1-vs-Stage3 |
1.851990E-01 |
| Stage1-vs-Stage4 |
4.399800E-01 |
| Stage2-vs-Stage3 |
1.461180E-03 |
| Stage2-vs-Stage4 |
1.116100E-02 |
| Stage3-vs-Stage4 |
8.258800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.553280E-04 |
| Normal-vs-AfricanAmerican |
3.173000E-01 |
| Normal-vs-Asian |
1.744060E-03 |
| Caucasian-vs-AfricanAmerican |
1.130420E-01 |
| Caucasian-vs-Asian |
9.883400E-01 |
| AfricanAmerican-vs-Asian |
1.218150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.982150E-03 |
| Normal-vs-Female |
1.201380E-03 |
| Male-vs-Female |
6.398200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.342900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.037400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.000450E-02 |
| Normal-vs-Age(81-100Yrs) |
1.250190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.342200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.733200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.608600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.474400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.453800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.164200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.818300E-03 |
| Classical-VS-Follicular |
1.045630E-01 |
| Classical-VS-Other |
1.180440E-01 |
| Classical-VS-Normal |
1.176100E-03 |
| Tall-VS-Follicular |
9.830500E-04 |
| Tall-VS-Other |
5.498000E-01 |
| Tall-VS-Normal |
1.51888999999628E-05 |
| Follicular-VS-Other |
8.017600E-02 |
| Follicular-VS-Normal |
2.070800E-01 |
| Other-VS-Normal |
5.579800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.383100E-03 |
| Normal-vs-N1 |
3.69880000000711E-05 |
| N0-vs-N1 |
3.771800E-02 |
|
|
